Brazil Approves First Generic Version Of Sovaldi
Executive Summary
Brazil’s first generic version of Sovaldi for hepatitis C is approved.
You may also be interested in...
Brazil Prepares To Make Its Own Sovaldi As Regulator Opposes Patent Application
Brazil could soon be manufacturing its own generic version of Gilead’s Sovaldi if opposition to the company’s patent application is upheld by the patent office.
Latin American Countries Set Up Joint Procurement Mechanism
Mercosur bloc has been conducting joint negotiations on HCV drugs; cancer treatments may be next on the agenda.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.